We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Prospective multicenter study evaluates PET biomarkers in hepatocellular carcinoma patients treated with sorafenib, revealing limited prognostic value.
F-FCH PET/CT does not provide additional prognostic information.
No takes yet. Share an insight, caveat, or question.
COCHET et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: